NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹189 Cr | ₹122 Cr | ₹147 Cr | ₹180 Cr | ₹170 Cr |
What is the latest Total Non-Current Liabilities ratio of NEULAND LABORATORIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹189 Cr |
Mar2024 | ₹122 Cr |
Mar2023 | ₹147 Cr |
Mar2022 | ₹180 Cr |
Mar2021 | ₹170 Cr |
How is Total Non-Current Liabilities of NEULAND LABORATORIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹189 Cr | 55.02 | |
Mar2024 | ₹122 Cr | -16.73 | |
Mar2023 | ₹147 Cr | -18.42 | |
Mar2022 | ₹180 Cr | 5.90 | |
Mar2021 | ₹170 Cr | - |
Compare Total Non-Current Liabilities of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹16,733.6 Cr | -6% | 12% | 51.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,731.0 Cr | -4.3% | -3% | -0.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,373.0 Cr | -3.3% | -7.4% | 34.1% | Stock Analytics | |
CIPLA | ₹122,411.0 Cr | -4.4% | -0.5% | 0.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,285.0 Cr | 1.4% | 10.1% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,270.0 Cr | -5.2% | -5.7% | -5.9% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | -6% |
12% |
51.7% |
SENSEX | 0.2% |
-2.7% |
-0.9% |
You may also like the below Video Courses